Full article view2017-09-21T08:01:31+00:00

Jena Discusses New PHE Preeclampsia Study With Orlando Sentinel


PHE Scientific Advisor Anupam Jena, coauthor of a new study on preeclampsia in the September issue of American Journal of Obstetrics & Gynecology, discussed the study’s findings and the growing economic impact of the condition with the Orlando Sentinel’s Amelia Cheatham.

The study by Jena and colleagues found that preeclampsia increases the probability of an adverse event for mothers and infants and lowers the gestational age. The authors estimated preeclampsia cost the US healthcare system an additional $2.18 billion above the usual maternal and infant costs in 2012. PHE’s study sheds light on an important health factor during pregnancy. “We don’t really know much about how preeclampsia impacts both the short-term and long-term health of mothers and their infants on a national scale,” Jena said.

To read the article in the Orlando Sentinel, please click here.

To read the study abstract as it appears in the American Journal of Obstetrics & Gynecology, please click here.

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

By continuing to use our website, you agree to our use of cookies to help us give you the best experience, analyze your site usage, and assist in our marketing efforts.
For more information, or to learn how to change your cookies preferences, please click here.